California Cancer Reporting System Standards, Volume III

IF1148: Mets at DX-BBDLLO, HemeRetic

OWNER

SEER

EDIT SETS

California Hospital Transmit

Eureka Admission Level

Eureka Tumor Level

FIELDS

Primary Site [NAACCR #400]

Histologic Type ICD-O-3 [NAACCR #522]

Behavior Code ICD-O-3 [NAACCR# 523]

Mets at DX-Bone [NAACCR #1112]

Mets at DX-Brain

Mets at DX-Distant LN

Mets at DX-Liver

Mets at DX-Lung

Mets at DX-Other

Date of Diagnosis [NAACCR #390]

Type of Reporting Source [NAACCR# 500]

TABLE

N/A

MESSAGE

  1. IF1148: Mets at DX fields are invalid for site/hist combination

specification

The purpose of this edit is to verify that the Mets at DX-Bone, Brain, Distant LN, Liver, Lung, and Other fields are coded to 8 (not applicable) for the appropriate site/histology combinations.

 

This edit is skipped if any of the following conditions are true:

  1. Year of Date of Diagnosis is less than 2016, blank (unknown), or invalid

  2. Type of Reporting Source = 7 (Death Certificate Only)

  3. Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline)

  4. Mets at DX fields are all empty

 

If site and histology are included in the Hematopoietic, Reticuloendothelial, Immunoproliferative, and Myeloproliferative Neoplasms, an error will be generated under any of the following conditions:

  1. If Mets at DX-Bone not = 8

  2. If Mets at DX-Brain not = 8

  3. If Mets at DX-Distant LN not = 8

  4. If Mets at DX-Liver not = 8

  5. If Mets at DX-Lung not = 8

  6. If Mets at DX-Other not = 8

 

If site and histology are NOT included in the Hematopoietic, Reticuloendothelial, Immunoproliferative, and Myeloproliferative Neoplasms, an error will be generated under any of the following conditions:

  1. If Mets at DX-Bone = 8

  2. If Mets at DX-Brain = 8

  3. If Mets at DX-Distant LN = 8

  4. If Mets at DX-Liver = 8

  5. If Mets at DX-Lung = 8

  6. If Mets at DX-Other = 8

 

The Hematopoietic, Reticuloendothelial, Immunoproliferative, and Myeloproliferative Neoplasms are identified within the edit logic as follows:

 

Heme1 - HemeRetic neoplasms for all sites: Histologic Type ICD-O-3 9740-9809,9840-9992

 

Heme2 - HemeRetic neoplasms except when occurring in Ocular Adnexal sites: Histologic Type ICD-O-3 9820, 9826, 9831-9834 with Primary Site C000-C440, C442-C689, C691-C694, C698-C809

 

Heme3 - Neoplasms manifesting as leukemia or lymphoma: Histologic Type ICD-O-3 9823, 9827, with Primary Site C420, C421, C424

 

Heme4 - Neoplasms accepted as either leukemia or lymphoma: Histologic Type ICD-O-3 9811-9818, 9837 with Primary Site C420, C421, C424. NOTE: Any valid code for a Mets at DX field will be accepted for this group of sites/histologies.

 

Plasma - Plasma Cell Disorders: Histologic Type ICD-O-3 9731, 9732, 9734 with Primary Site C000-C440, C442-C689, C691-C694, C698-C809

historical changes

In the SEER*Edits software, the title of this edit is: IF619.

08/2016

Per NAACCR v16, new edit added.

11/2016

Per NAACCR v16B, modified Description, Edit Logic to identify histology codes 9811-9818, 9837, with primary site C420, C421, and C424 as a separate group (Heme4 for this edit), which can be coded as either hematopoietic or lymphoid malignancy, according to agreement reached between SEER and COC.  All valid codes are accepted in the Mets at DX fields for this group.

11/2016

Per NAACCR v16C, edit logic corrected to pass all valid codes for histology codes 9811-9818, 9837, for primary site C420, C421, and C424.